Supic G, Kozomara R, Zeljic K, Stanimirovic D, Magic M, Surbatovic M, Jovic N, Magic Z
Faculty of Medicine, Military Medical Academy, University of Defense, Belgrade, Serbia; Institute for Medical Research, Military Medical Academy, Belgrade, Serbia.
Oral Dis. 2015 May;21(4):536-43. doi: 10.1111/odi.12318. Epub 2015 Feb 26.
This study examined the single nucleotide polymorphisms (SNPs) in high-mobility group box 1 (HMGB1) gene in patients with oral squamous cell carcinoma (OSCC) and oral lichen planus (OLP).
The study was conducted on 93 patients with OSCC, 53 patients with OLP, and 100 controls, all Caucasians of the same ethnicity, matched by age. HMGB1 genotypes for 4 SNPs, 2262G/A (rs1045411), 1177G/C (rs3742305), 3814C/G (rs2249825), and rs4540927, were assessed using TaqMan SNP Genotyping Assays, Applied Biosystems.
The HMGB1 1177GG genotype was associated with lymph-node metastasis and tumor stage in OSCCs (P = 0.016 and P = 0.030, respectively). Genotype 1177GG resulted in poorer recurrence-free survival (RFS), P = 0.000. The 1177G/C polymorphism was an independent predictor of RFS compared to GG genotype, P = 0.001. The three polymorphisms were in linkage disequilibrium (LD). The AGC and GGC haplotypes were associated with an increased oral cancer risk, determined over the haplotype odds ratios (HOR = 13.316, P = 0.015, and HOR = 5.769, P = 0.029, respectively). The AGC haplotype was related to erosive OLP progression to OSCC (HOR = 12.179, P = 0.001).
HMGB1 polymorphism 1177G/C could be associated with tumor progression and recurrence-free survival in patients with OSCC. The haplotypes of HMGB1 gene might be associated with susceptibility to OSCC and OLP progression to OSCC.
本研究检测口腔鳞状细胞癌(OSCC)和口腔扁平苔藓(OLP)患者高迁移率族蛋白B1(HMGB1)基因的单核苷酸多态性(SNP)。
本研究纳入93例OSCC患者、53例OLP患者和100例对照,均为年龄匹配的同种族白种人。使用应用生物系统公司的TaqMan SNP基因分型检测法评估HMGB1基因4个SNP(2262G/A,rs1045411;1177G/C,rs3742305;3814C/G,rs2249825;以及rs4540927)的基因型。
HMGB1基因1177GG基因型与OSCC患者的淋巴结转移和肿瘤分期相关(分别为P = 0.016和P = 0.030)。1177GG基因型导致无复发生存期(RFS)较差,P = 0.000。与GG基因型相比,1177G/C多态性是RFS的独立预测因子,P = 0.001。这三个多态性处于连锁不平衡(LD)状态。AGC和GGC单倍型与口腔癌风险增加相关,通过单倍型优势比确定(分别为HOR = 13.316,P = 0.015;以及HOR = 5.769,P = 0.029)。AGC单倍型与糜烂性OLP进展为OSCC相关(HOR = 12.179,P = 0.001)。
HMGB1基因多态性1177G/C可能与OSCC患者的肿瘤进展和无复发生存期相关。HMGB1基因的单倍型可能与OSCC易感性以及OLP进展为OSCC相关。